Alpha 1-antitrypsin in patients with hepatocellular carcinoma and chronic active hepatitis

Clin Genet. 1981 Feb;19(2):134-9. doi: 10.1111/j.1399-0004.1981.tb00684.x.

Abstract

Forty-seven Italian patients suffering from hepatocellular carcinoma (HCC) and 58 patients with chronic active hepatitis (CAH) were screened for alpha 1-antitrypsin (alpha 1 AT) levels and types and compared with a previously screened healthy Italian population. Serum alpha 1 AT concentrations were significantly raised among the HCC patients compared to the controls, whereas the CAH group showed no differences. The incidence of non-M phenotypes (MS, MZ and S) is significantly higher in patients with HCC than in the CAH group and the controls. The mean age of HCC patients with a non-M phenotype is significantly lower than the mean age of HCC patients with an M phenotype.

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Hepatocellular / blood
  • Carcinoma, Hepatocellular / genetics*
  • Chronic Disease
  • Gene Frequency
  • Hepatitis / blood
  • Hepatitis / genetics*
  • Humans
  • Liver Neoplasms / blood
  • Liver Neoplasms / genetics*
  • Middle Aged
  • Phenotype
  • alpha 1-Antitrypsin / genetics*

Substances

  • alpha 1-Antitrypsin